Despite growing enthusiasm for transcather aortic valve replacement (TAVR) procedures, Belgian researchers wrote that they have serious concerns about the treatments clinical outcomes and cost-effectiveness. In an analysis published July 31 in BMJ, they listed TAVRs approval process, lack of transparency and a disconnect between practice and clinical evidence among their concerns.

David J. Drachman, CEO and president of AtriCure, has announced his resignation. Drachman will continue to serve the company through Sept. 30.

In a real-world setting, many administrators struggle to balance pinching pennies and delivering care. As hospital reimbursement dwindles and innovation blossoms, hospital staff must find creative ways to save a buck without skimping on care. Staff members from three hospitals share their solutions ranging from data dissemination to innovation to physician engagement.

Latest in Cardiac Surgery & CABG

Hybrid operating rooms promise to deliver multiple benefits, but they represent a hefty investment and require meticulous planning.

Fractional flow reserve is a valuable asset in cardiac cath labs for assessing ischemia-causing lesions. But two new approaches soon may provide alternatives.

Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring, has posted a strong second quarter, showing an increase in sales and net income over the previous year's second quarter.

Total hip replacement and total knee replacement surgeries were associated with increased risk of acute MI in the first two weeks after the surgical procedures, according to a registry study published July 23 in the Archives of Internal Medicine.